5 Recruiting Studies Using Efgartigimod Iv
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Efgartigimod Iv
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
📍 HonorHealth Neurology - Bob Bove Neuroscience Institute — Scottsdale, Arizona
Generalized Myasthenia Gravis
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
📍 Profound Research LLC - Carlsbad — Carlsbad, California
Myasthenia Gravis
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
📍 Profound Research LLC - Carlsbad — Carlsbad, California
AChR-Ab Seropositive Generalized Myasthenia Gravis
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
📍 Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital — Chicago, Illinois
Generalized Myasthenia Gravis
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
📍 Mayo Clinic Hospital Scottsdale — Phoenix, Arizona
Primary Immune Thrombocytopenia (ITP)
View Study & Checklist ➔